Table 1. Description of pool samples.
| Plasma-DMSO pools for proteomics | Plasma pools for WB* | |||||
| Inactive CE pools (IP) | Cyst stage | pool 1i | pool 2i | pool 3i | Cyst stage | pool WBi |
| 25 samples, 28 ml | 25 samples, 27 ml | 26 samples, 27 ml | 48 samples, 30 ml | |||
| CE4 | 12 | 13 | 13 | CE4 | 19 | |
| 76 Total samples: | CE4/CE4 | 4 | 4 | 4 | CE4/CE4 | 8 |
| 66% Pavia Hospital | CE4+PSC | 1 | CE4+PSC | 1 | ||
| 20% Turkey | CE4/CE4/CE4/CE4 | 0.5 | 0.5 | CE4/CE4/CE4/CE4 | 1 | |
| 14% Romania | CE5 | 6 | 4 | 5 | CE5 | 14 |
| CE5/CE5 | 1 | 1 | CE5+PSC | 3 | ||
| CE5+PSC | 1.5 | 1.5 | CE5/CE5/CE5 | 1 | ||
| CE5/CE5/CE5 | 1 | CE5/CE4/CE5 | 1 | |||
| CE5/CE4/CE5 | 1 | |||||
| pool 2a | pool 3a | pool WBa | ||||
| Active CE pools (AP) | 25 samples, 26 ml | 23 samples, 25 ml | 25 samples, 30 ml | |||
| CE1 | 3 | 4 | CE1 | 1 | ||
| 46 Total samples: | CE2 | 3 | 3 | CE2 | 1 | |
| 56% Pavia Hospital | CE3b | 13 | 12 | CE3b | 20 | |
| 31% Turkey | CE1/CE1 | 2 | 2 | CE3b/CE2/CE1/CE1 | 1 | |
| 13% Romania | CE1/CE2 | 1 | 1 | CE4/CE3b/CE3b | 1 | |
| CE3b/CE4 | 1 | CE4/CE3b/CE3b | 2 | |||
| CE3b/CE2/CE1/CE1 | 1 | |||||
| CE4/CE3b/CE3b | 1 | 1 | ||||
| Control pools (Ctr) | 70 Total samples: 80% Turkey; 20% Pavia Hospital. C1 = 25ml; C2 = 50ml. | * all CE samples were from Pavia Hospital while control samples (30 ml) from Turkey | ||||